SlideShare ist ein Scribd-Unternehmen logo
1 von 16
Downloaden Sie, um offline zu lesen
ReaPanMicro:  Presence/Absence Test for Bacteria in Urine
What is ReaPanMicro? A diagnostic test to  confirm  the absence of bacteria in urine, based on the principle of nucleic acid detection in bacteria on a fluorescence event detector such as a flow cytometer ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],By Culture 119 43 TN 99.2 NPV 67.7% PPV 1 Negative by Flow 90 Positive by Flow TP Overall
Initial Studies on Clinical Urine Samples
Experimental Design: Staining of Clinical Urine Samples Training Set 6 culture negative (<10,000 CFU/mL) clinical urine samples 6 highly positive (>100,000 CFU/mL) clinical urine samples These 12 samples were used to determine the ideal gating strategy Staining Protocol using Reagents Filter 1 mL urine sample through a 11 um Syringe Filter into a 1.5 mL eppendorf tube Add 900 uL of the filtered urine to FACStube filled with 50 uL of nucleic acid stain and 10,000 volume control beads. Add 50 uL of PFA to fix Vortex and incubate for 5 min Run the sample on the Flow Cytometer using pre-set template Filtering is done only to remove any uric acid crystals, and “debris”
Running the Test: Workflow Envisaged  ID’ing FACSTube with dried down reagent:  1 min Filtering  900 uL of urine sample into FACStube using enclosed syringe filter 2 min Vortex and incubate sample at RT 5 min Run MilliQ water tube thru FACScan 1 min Acquire data on FACScan with vortexed patient sample 2 min Time to Result:  Within 15 min of sample reaching instrument
Calibration Beads Before the gain on the PMT’s are adjusted After the gain on the PMT’s are adjusted Setting up the template : Intensity Control Beads Determine Appropriate Gain Settings on the Instrument Gate where bacterial events are collected Gate where bacterial events are collected
Gating Strategy Optimized using 12 Training Set Samples Counts (Arbitrary Units) Culture Negative (Less than 10,000 CFU/mL) Culture Positive (More than 100,000 CFU/mL) ReaMetrix Confidential 85.24 counts per unit volume 40083 counts per unit volume Counts (Arbitrary  Units) Region R6 gate has been  applied
Statistical Analysis to Determine  Decision Threshold  using N = 253 samples Counts Scatter Plots of Bacterial Counts from Flow Cytometry N = 91 N = 162 N = 91 N = 162 Counts Mean Counts N = 91
Statistical Analysis to Determine Decision Threshold using N = 253 samples Zooming in : Exception Analysis and Identifying the Gray Region This definitely could not have been negative by culture. We will look at other clinical investigations that were done on these samples  N = 29 (18% of negatives) N = 68 (75% of positives) Counts Gray Region  N = 17 (11% of negatives) N = 22 (24% of positives) Could these samples have all been similar in some respect?  0-3000 counts 3000-10000 counts > 10000 counts N = 116 (72% of negatives) N = 1  (1% of positives)
Statistical Analysis of 253 Clinical Samples tested thus far Threshold defined using the training set. Threshold was set to ensure that NPV was 100% TP = True Positive at that level using culture as Gold Standard TN = True Negative at that level using culture as Gold Standard PPV - Positive Predictive Value  NPV - Negative Predictive Value  By Culture     By Culture By Flow CFU/mL Arb Units Negative < 10000 < 3,000 Positive > 100000 > 3,000 119 43 TN 99.2 NPV 67.7% PPV 1 Negative by Flow 90 Positive by Flow TP Overall
Samples Stained with just TO without formaldehyde and  stored at 4C overnight (N=22 samples) Y Axis:  Counts measured on samples immediately after staining X Axis:  Counts measured on samples stained and kept at 4 C for 24 hrs. No fixative was used Red Square Points:  Indicative of False Positive samples as per culture results False Positive Zone:  Samples that lie in this rectangle refer to those that show high counts deeming them positive, 24 hrs later, but were negative when counted immediately after staining False Negative Zone:  Samples that lie in this rectangle refer to those that show low counts deeming them negative, 24 hrs later, but were positive when counted immediately after staining We find no samples in the False Positive or False Negative Zones.  Thus the stained samples can be transported after fixing
Transferring the assay to Diagnostic Lab :  Instrument Set Up Protocol using ReaTCount Beads User will open SSC, FL1, FL2, FL3 histograms in a template and set the gains on these channels to get channel numbers within the specifications given below.  On 5 different days the maximum variation seen for the same gain is no more than 2 channel numbers on any of the channels We ran experiments to determine , what is the variation that is tolerable (that does not impact counts by more than 10%) We have found that up-to 3 channel numbers variation about either side of the mean does not impact the counts seen in urine samples If the set up is within spec, the threshold is then set on FL1 at channel number 215
Quantifying the Maximum Variability in Counts Seen with Assay Repeats (Assessing the robustness of the finalized assay protocol) 6 culture positive and 4 culture negative samples were filtered and stained in triplicate, to determine the assay variability seen with the finalized protocol. The assay variability is typically less than 15%. Thus the gray region for the threshold of 3000 is nearly +/- 450 counts
ReaTCount Volume Control Beads  FL3 – LDS stained cells are gated on R9 R9 gate is applied on FL1 to get counts using M1 Proof of concepts experiments –  Dual Staining of Bacteria using LDS and Thiazole Orange NEGATIVE URINE SAMPLES POSITIVE URINE SAMPLES
Conclusion ,[object Object],[object Object]
Manufactured by ReaMetrix India Pvt. Ltd. 50-B, II Phase, Peenya Industrial Area Peenya, Bangalore 560058, India Ph: +91-80-28378693/5, Fax: +91-80-41172451 E-mail: info@reametrix.com www.reametrix.com  Further details:

Weitere ähnliche Inhalte

Was ist angesagt?

Poster 45 biochimie
Poster 45 biochimiePoster 45 biochimie
Poster 45 biochimieJIB Congress
 
Xpert- MTB-RIF Data _Biman
Xpert- MTB-RIF Data _BimanXpert- MTB-RIF Data _Biman
Xpert- MTB-RIF Data _BimanBiman Dey
 
Clinical Utility of Droplet Digital PCR on Liquid Biopsies from Patients with...
Clinical Utility of Droplet Digital PCR on Liquid Biopsies from Patients with...Clinical Utility of Droplet Digital PCR on Liquid Biopsies from Patients with...
Clinical Utility of Droplet Digital PCR on Liquid Biopsies from Patients with...Kate Barlow
 
Corona update 11 :: TESTING FOR CORONA VIRUS
Corona update 11 :: TESTING FOR CORONA VIRUSCorona update 11 :: TESTING FOR CORONA VIRUS
Corona update 11 :: TESTING FOR CORONA VIRUSNARENDRA MALHOTRA
 
10 Tips to maximize your Real Time PCR Success - Download the Technical Note
10 Tips to maximize your Real Time PCR Success - Download the Technical Note10 Tips to maximize your Real Time PCR Success - Download the Technical Note
10 Tips to maximize your Real Time PCR Success - Download the Technical NoteQIAGEN
 
Nucleic acid amplification technology (nat) test
Nucleic acid amplification technology (nat) testNucleic acid amplification technology (nat) test
Nucleic acid amplification technology (nat) testMEEQAT HOSPITAL
 

Was ist angesagt? (7)

Poster 45 biochimie
Poster 45 biochimiePoster 45 biochimie
Poster 45 biochimie
 
Xpert- MTB-RIF Data _Biman
Xpert- MTB-RIF Data _BimanXpert- MTB-RIF Data _Biman
Xpert- MTB-RIF Data _Biman
 
Clinical Utility of Droplet Digital PCR on Liquid Biopsies from Patients with...
Clinical Utility of Droplet Digital PCR on Liquid Biopsies from Patients with...Clinical Utility of Droplet Digital PCR on Liquid Biopsies from Patients with...
Clinical Utility of Droplet Digital PCR on Liquid Biopsies from Patients with...
 
Genexpert
GenexpertGenexpert
Genexpert
 
Corona update 11 :: TESTING FOR CORONA VIRUS
Corona update 11 :: TESTING FOR CORONA VIRUSCorona update 11 :: TESTING FOR CORONA VIRUS
Corona update 11 :: TESTING FOR CORONA VIRUS
 
10 Tips to maximize your Real Time PCR Success - Download the Technical Note
10 Tips to maximize your Real Time PCR Success - Download the Technical Note10 Tips to maximize your Real Time PCR Success - Download the Technical Note
10 Tips to maximize your Real Time PCR Success - Download the Technical Note
 
Nucleic acid amplification technology (nat) test
Nucleic acid amplification technology (nat) testNucleic acid amplification technology (nat) test
Nucleic acid amplification technology (nat) test
 

Andere mochten auch

bacterial-bioluminescence
bacterial-bioluminescencebacterial-bioluminescence
bacterial-bioluminescenceMerlyn Denesia
 
Four corners diseasejp seminar
Four corners diseasejp  seminarFour corners diseasejp  seminar
Four corners diseasejp seminarRangineni Prada
 
Endolithic Bacteria In Low Temperature Environment, A Case of Life on Mars
Endolithic Bacteria In Low Temperature Environment, A Case of Life on Mars Endolithic Bacteria In Low Temperature Environment, A Case of Life on Mars
Endolithic Bacteria In Low Temperature Environment, A Case of Life on Mars Sayantani Nath
 
Bioluminescence mechanism
Bioluminescence mechanismBioluminescence mechanism
Bioluminescence mechanismpurvi gosrani
 
Influenza epidemiology
Influenza epidemiologyInfluenza epidemiology
Influenza epidemiologyAshraf ElAdawy
 
Medical mycology
Medical mycologyMedical mycology
Medical mycologyGopi sankar
 

Andere mochten auch (6)

bacterial-bioluminescence
bacterial-bioluminescencebacterial-bioluminescence
bacterial-bioluminescence
 
Four corners diseasejp seminar
Four corners diseasejp  seminarFour corners diseasejp  seminar
Four corners diseasejp seminar
 
Endolithic Bacteria In Low Temperature Environment, A Case of Life on Mars
Endolithic Bacteria In Low Temperature Environment, A Case of Life on Mars Endolithic Bacteria In Low Temperature Environment, A Case of Life on Mars
Endolithic Bacteria In Low Temperature Environment, A Case of Life on Mars
 
Bioluminescence mechanism
Bioluminescence mechanismBioluminescence mechanism
Bioluminescence mechanism
 
Influenza epidemiology
Influenza epidemiologyInfluenza epidemiology
Influenza epidemiology
 
Medical mycology
Medical mycologyMedical mycology
Medical mycology
 

Ähnlich wie ReaPanMicro Bacteria Test

chlamydia nucleic acid amplification tests
chlamydia nucleic acid amplification testschlamydia nucleic acid amplification tests
chlamydia nucleic acid amplification testsmorteza karami
 
What is Nephelometry,and a fully automated Nephlometer analyzer for protein a...
What is Nephelometry,and a fully automated Nephlometer analyzer for protein a...What is Nephelometry,and a fully automated Nephlometer analyzer for protein a...
What is Nephelometry,and a fully automated Nephlometer analyzer for protein a...Shahid Nawaz
 
Internal quality control (IQC) in coagulation lab
Internal quality control (IQC) in coagulation labInternal quality control (IQC) in coagulation lab
Internal quality control (IQC) in coagulation labAnkit Raiyani
 
Evaluation of Automated COBAS AMPLICOR PCR System for Detection of Several In...
Evaluation of Automated COBAS AMPLICOR PCR System for Detection of Several In...Evaluation of Automated COBAS AMPLICOR PCR System for Detection of Several In...
Evaluation of Automated COBAS AMPLICOR PCR System for Detection of Several In...Alberto Cuadrado
 
Dr. Jeff Baxter - Lab Testing Standardization
Dr. Jeff Baxter - Lab Testing StandardizationDr. Jeff Baxter - Lab Testing Standardization
Dr. Jeff Baxter - Lab Testing StandardizationJohn Blue
 
Application of MicroTester for detection of low microbial contamination
Application of MicroTester for detection of low microbial contaminationApplication of MicroTester for detection of low microbial contamination
Application of MicroTester for detection of low microbial contaminationOlivér Reichart
 
miniPCR-P51-Intro-to-qPCR-Lab-Classroom-slides_v1-4.pptx
miniPCR-P51-Intro-to-qPCR-Lab-Classroom-slides_v1-4.pptxminiPCR-P51-Intro-to-qPCR-Lab-Classroom-slides_v1-4.pptx
miniPCR-P51-Intro-to-qPCR-Lab-Classroom-slides_v1-4.pptxShakilHaque6
 
DNA Extraction and Quantity-Quality Check
DNA Extraction and Quantity-Quality CheckDNA Extraction and Quantity-Quality Check
DNA Extraction and Quantity-Quality CheckRayhan Shahrear
 
Comparación métodos detección carbapenemasas.pptx
Comparación métodos detección carbapenemasas.pptxComparación métodos detección carbapenemasas.pptx
Comparación métodos detección carbapenemasas.pptxnp4gck54qg
 
Diagnosis of tuberculosis.pptx
Diagnosis of tuberculosis.pptxDiagnosis of tuberculosis.pptx
Diagnosis of tuberculosis.pptxDarshnaSarvaiya2
 
Analytical Method Validation basics by Dr. A. Amsavel
Analytical Method Validation  basics by Dr. A. AmsavelAnalytical Method Validation  basics by Dr. A. Amsavel
Analytical Method Validation basics by Dr. A. AmsavelDr. Amsavel A
 
Diagnostic modalities in tuberculosis
Diagnostic modalities in tuberculosisDiagnostic modalities in tuberculosis
Diagnostic modalities in tuberculosisbiplave karki
 
PSP2 Oral Project Presentation Slides
PSP2 Oral Project Presentation SlidesPSP2 Oral Project Presentation Slides
PSP2 Oral Project Presentation SlidesMeganDutton1
 
what is new in prevention, diagnosis and treatment of tuberculosis tb short.pptx
what is new in prevention, diagnosis and treatment of tuberculosis tb short.pptxwhat is new in prevention, diagnosis and treatment of tuberculosis tb short.pptx
what is new in prevention, diagnosis and treatment of tuberculosis tb short.pptxPathKind Labs
 
Real time pcr
Real time pcrReal time pcr
Real time pcrali h
 
Analytical Validation of the Oncomine™ Comprehensive Assay v3 with FFPE and C...
Analytical Validation of the Oncomine™ Comprehensive Assay v3 with FFPE and C...Analytical Validation of the Oncomine™ Comprehensive Assay v3 with FFPE and C...
Analytical Validation of the Oncomine™ Comprehensive Assay v3 with FFPE and C...Thermo Fisher Scientific
 
BME 302 Cellular Engineering Common Cell & Molecu.docx
BME 302 Cellular Engineering  Common Cell & Molecu.docxBME 302 Cellular Engineering  Common Cell & Molecu.docx
BME 302 Cellular Engineering Common Cell & Molecu.docxhartrobert670
 

Ähnlich wie ReaPanMicro Bacteria Test (20)

chlamydia nucleic acid amplification tests
chlamydia nucleic acid amplification testschlamydia nucleic acid amplification tests
chlamydia nucleic acid amplification tests
 
What is Nephelometry,and a fully automated Nephlometer analyzer for protein a...
What is Nephelometry,and a fully automated Nephlometer analyzer for protein a...What is Nephelometry,and a fully automated Nephlometer analyzer for protein a...
What is Nephelometry,and a fully automated Nephlometer analyzer for protein a...
 
Internal quality control (IQC) in coagulation lab
Internal quality control (IQC) in coagulation labInternal quality control (IQC) in coagulation lab
Internal quality control (IQC) in coagulation lab
 
Evaluation of Automated COBAS AMPLICOR PCR System for Detection of Several In...
Evaluation of Automated COBAS AMPLICOR PCR System for Detection of Several In...Evaluation of Automated COBAS AMPLICOR PCR System for Detection of Several In...
Evaluation of Automated COBAS AMPLICOR PCR System for Detection of Several In...
 
Dr. Jeff Baxter - Lab Testing Standardization
Dr. Jeff Baxter - Lab Testing StandardizationDr. Jeff Baxter - Lab Testing Standardization
Dr. Jeff Baxter - Lab Testing Standardization
 
Application of MicroTester for detection of low microbial contamination
Application of MicroTester for detection of low microbial contaminationApplication of MicroTester for detection of low microbial contamination
Application of MicroTester for detection of low microbial contamination
 
miniPCR-P51-Intro-to-qPCR-Lab-Classroom-slides_v1-4.pptx
miniPCR-P51-Intro-to-qPCR-Lab-Classroom-slides_v1-4.pptxminiPCR-P51-Intro-to-qPCR-Lab-Classroom-slides_v1-4.pptx
miniPCR-P51-Intro-to-qPCR-Lab-Classroom-slides_v1-4.pptx
 
DNA Extraction and Quantity-Quality Check
DNA Extraction and Quantity-Quality CheckDNA Extraction and Quantity-Quality Check
DNA Extraction and Quantity-Quality Check
 
Comparación métodos detección carbapenemasas.pptx
Comparación métodos detección carbapenemasas.pptxComparación métodos detección carbapenemasas.pptx
Comparación métodos detección carbapenemasas.pptx
 
Validation my ppt
Validation my pptValidation my ppt
Validation my ppt
 
Diagnosis of tuberculosis.pptx
Diagnosis of tuberculosis.pptxDiagnosis of tuberculosis.pptx
Diagnosis of tuberculosis.pptx
 
Analytical Method Validation basics by Dr. A. Amsavel
Analytical Method Validation  basics by Dr. A. AmsavelAnalytical Method Validation  basics by Dr. A. Amsavel
Analytical Method Validation basics by Dr. A. Amsavel
 
Nat Testing
Nat TestingNat Testing
Nat Testing
 
Diagnostic modalities in tuberculosis
Diagnostic modalities in tuberculosisDiagnostic modalities in tuberculosis
Diagnostic modalities in tuberculosis
 
PSP2 Oral Project Presentation Slides
PSP2 Oral Project Presentation SlidesPSP2 Oral Project Presentation Slides
PSP2 Oral Project Presentation Slides
 
what is new in prevention, diagnosis and treatment of tuberculosis tb short.pptx
what is new in prevention, diagnosis and treatment of tuberculosis tb short.pptxwhat is new in prevention, diagnosis and treatment of tuberculosis tb short.pptx
what is new in prevention, diagnosis and treatment of tuberculosis tb short.pptx
 
Real time pcr
Real time pcrReal time pcr
Real time pcr
 
Analytical Validation of the Oncomine™ Comprehensive Assay v3 with FFPE and C...
Analytical Validation of the Oncomine™ Comprehensive Assay v3 with FFPE and C...Analytical Validation of the Oncomine™ Comprehensive Assay v3 with FFPE and C...
Analytical Validation of the Oncomine™ Comprehensive Assay v3 with FFPE and C...
 
BME 302 Cellular Engineering Common Cell & Molecu.docx
BME 302 Cellular Engineering  Common Cell & Molecu.docxBME 302 Cellular Engineering  Common Cell & Molecu.docx
BME 302 Cellular Engineering Common Cell & Molecu.docx
 
CBNAAT
CBNAATCBNAAT
CBNAAT
 

Mehr von zmanian

Hiv Presentation Asicon
Hiv Presentation AsiconHiv Presentation Asicon
Hiv Presentation Asiconzmanian
 
ReaPan B27
ReaPan B27ReaPan B27
ReaPan B27zmanian
 
ReaMetrix Hiv Reagent Portfolio
ReaMetrix Hiv Reagent PortfolioReaMetrix Hiv Reagent Portfolio
ReaMetrix Hiv Reagent Portfoliozmanian
 
ReaMetrix Overview
ReaMetrix OverviewReaMetrix Overview
ReaMetrix Overviewzmanian
 
Towards 
Indigenously 
Developed,

 Locally 
Relevant,
Affordable 
Diagnosics

Towards 
Indigenously 
Developed,

 Locally 
Relevant,
Affordable 
Diagnosics
Towards 
Indigenously 
Developed,

 Locally 
Relevant,
Affordable 
Diagnosics

Towards 
Indigenously 
Developed,

 Locally 
Relevant,
Affordable 
Diagnosics
zmanian
 
Changing the Paradigm-Affordability and Access Sustainabilty
Changing the Paradigm-Affordability and Access SustainabiltyChanging the Paradigm-Affordability and Access Sustainabilty
Changing the Paradigm-Affordability and Access Sustainabiltyzmanian
 
Affordability Through Sustainability
Affordability Through SustainabilityAffordability Through Sustainability
Affordability Through Sustainabilityzmanian
 
Affordable Diagnostics
Affordable DiagnosticsAffordable Diagnostics
Affordable Diagnosticszmanian
 

Mehr von zmanian (8)

Hiv Presentation Asicon
Hiv Presentation AsiconHiv Presentation Asicon
Hiv Presentation Asicon
 
ReaPan B27
ReaPan B27ReaPan B27
ReaPan B27
 
ReaMetrix Hiv Reagent Portfolio
ReaMetrix Hiv Reagent PortfolioReaMetrix Hiv Reagent Portfolio
ReaMetrix Hiv Reagent Portfolio
 
ReaMetrix Overview
ReaMetrix OverviewReaMetrix Overview
ReaMetrix Overview
 
Towards 
Indigenously 
Developed,

 Locally 
Relevant,
Affordable 
Diagnosics

Towards 
Indigenously 
Developed,

 Locally 
Relevant,
Affordable 
Diagnosics
Towards 
Indigenously 
Developed,

 Locally 
Relevant,
Affordable 
Diagnosics

Towards 
Indigenously 
Developed,

 Locally 
Relevant,
Affordable 
Diagnosics

 
Changing the Paradigm-Affordability and Access Sustainabilty
Changing the Paradigm-Affordability and Access SustainabiltyChanging the Paradigm-Affordability and Access Sustainabilty
Changing the Paradigm-Affordability and Access Sustainabilty
 
Affordability Through Sustainability
Affordability Through SustainabilityAffordability Through Sustainability
Affordability Through Sustainability
 
Affordable Diagnostics
Affordable DiagnosticsAffordable Diagnostics
Affordable Diagnostics
 

Kürzlich hochgeladen

PULMONARY EDEMA AND ITS MANAGEMENT.pdf
PULMONARY EDEMA AND  ITS  MANAGEMENT.pdfPULMONARY EDEMA AND  ITS  MANAGEMENT.pdf
PULMONARY EDEMA AND ITS MANAGEMENT.pdfDolisha Warbi
 
PHYSIOTHERAPY IN HEART TRANSPLANTATION..
PHYSIOTHERAPY IN HEART TRANSPLANTATION..PHYSIOTHERAPY IN HEART TRANSPLANTATION..
PHYSIOTHERAPY IN HEART TRANSPLANTATION..AneriPatwari
 
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...
Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...sdateam0
 
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...Wessex Health Partners
 
Nutrition of OCD for my Nutritional Neuroscience Class
Nutrition of OCD for my Nutritional Neuroscience ClassNutrition of OCD for my Nutritional Neuroscience Class
Nutrition of OCD for my Nutritional Neuroscience Classmanuelazg2001
 
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand UniversityCEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand UniversityHarshChauhan475104
 
Valproic Acid. (VPA). Antiseizure medication
Valproic Acid.  (VPA). Antiseizure medicationValproic Acid.  (VPA). Antiseizure medication
Valproic Acid. (VPA). Antiseizure medicationMohamadAlhes
 
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptxSYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptxdrashraf369
 
Presentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPresentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPrerana Jadhav
 
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdfLippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdfSreeja Cherukuru
 
medico legal aspects of wound - forensic medicine
medico legal aspects of wound - forensic medicinemedico legal aspects of wound - forensic medicine
medico legal aspects of wound - forensic medicinethanaram patel
 
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Badalona Serveis Assistencials
 
History and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfHistory and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfSasikiranMarri
 
Role of medicinal and aromatic plants in national economy PDF.pdf
Role of medicinal and aromatic plants in national economy PDF.pdfRole of medicinal and aromatic plants in national economy PDF.pdf
Role of medicinal and aromatic plants in national economy PDF.pdfDivya Kanojiya
 
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptxPresentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptxpdamico1
 
Introduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiIntroduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiGoogle
 
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurMETHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurNavdeep Kaur
 
Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.ANJALI
 
Screening for colorectal cancer AAU.pptx
Screening for colorectal cancer AAU.pptxScreening for colorectal cancer AAU.pptx
Screening for colorectal cancer AAU.pptxtadehabte
 

Kürzlich hochgeladen (20)

PULMONARY EDEMA AND ITS MANAGEMENT.pdf
PULMONARY EDEMA AND  ITS  MANAGEMENT.pdfPULMONARY EDEMA AND  ITS  MANAGEMENT.pdf
PULMONARY EDEMA AND ITS MANAGEMENT.pdf
 
PHYSIOTHERAPY IN HEART TRANSPLANTATION..
PHYSIOTHERAPY IN HEART TRANSPLANTATION..PHYSIOTHERAPY IN HEART TRANSPLANTATION..
PHYSIOTHERAPY IN HEART TRANSPLANTATION..
 
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...
Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...
 
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
 
Nutrition of OCD for my Nutritional Neuroscience Class
Nutrition of OCD for my Nutritional Neuroscience ClassNutrition of OCD for my Nutritional Neuroscience Class
Nutrition of OCD for my Nutritional Neuroscience Class
 
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand UniversityCEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
 
Valproic Acid. (VPA). Antiseizure medication
Valproic Acid.  (VPA). Antiseizure medicationValproic Acid.  (VPA). Antiseizure medication
Valproic Acid. (VPA). Antiseizure medication
 
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptxSYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
 
Presentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPresentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous System
 
JANGAMA VISHA .pptx-
JANGAMA VISHA .pptx-JANGAMA VISHA .pptx-
JANGAMA VISHA .pptx-
 
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdfLippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
 
medico legal aspects of wound - forensic medicine
medico legal aspects of wound - forensic medicinemedico legal aspects of wound - forensic medicine
medico legal aspects of wound - forensic medicine
 
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
 
History and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfHistory and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdf
 
Role of medicinal and aromatic plants in national economy PDF.pdf
Role of medicinal and aromatic plants in national economy PDF.pdfRole of medicinal and aromatic plants in national economy PDF.pdf
Role of medicinal and aromatic plants in national economy PDF.pdf
 
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptxPresentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
 
Introduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiIntroduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali Rai
 
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurMETHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
 
Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.
 
Screening for colorectal cancer AAU.pptx
Screening for colorectal cancer AAU.pptxScreening for colorectal cancer AAU.pptx
Screening for colorectal cancer AAU.pptx
 

ReaPanMicro Bacteria Test

  • 1. ReaPanMicro: Presence/Absence Test for Bacteria in Urine
  • 2.
  • 3. Initial Studies on Clinical Urine Samples
  • 4. Experimental Design: Staining of Clinical Urine Samples Training Set 6 culture negative (<10,000 CFU/mL) clinical urine samples 6 highly positive (>100,000 CFU/mL) clinical urine samples These 12 samples were used to determine the ideal gating strategy Staining Protocol using Reagents Filter 1 mL urine sample through a 11 um Syringe Filter into a 1.5 mL eppendorf tube Add 900 uL of the filtered urine to FACStube filled with 50 uL of nucleic acid stain and 10,000 volume control beads. Add 50 uL of PFA to fix Vortex and incubate for 5 min Run the sample on the Flow Cytometer using pre-set template Filtering is done only to remove any uric acid crystals, and “debris”
  • 5. Running the Test: Workflow Envisaged ID’ing FACSTube with dried down reagent: 1 min Filtering 900 uL of urine sample into FACStube using enclosed syringe filter 2 min Vortex and incubate sample at RT 5 min Run MilliQ water tube thru FACScan 1 min Acquire data on FACScan with vortexed patient sample 2 min Time to Result: Within 15 min of sample reaching instrument
  • 6. Calibration Beads Before the gain on the PMT’s are adjusted After the gain on the PMT’s are adjusted Setting up the template : Intensity Control Beads Determine Appropriate Gain Settings on the Instrument Gate where bacterial events are collected Gate where bacterial events are collected
  • 7. Gating Strategy Optimized using 12 Training Set Samples Counts (Arbitrary Units) Culture Negative (Less than 10,000 CFU/mL) Culture Positive (More than 100,000 CFU/mL) ReaMetrix Confidential 85.24 counts per unit volume 40083 counts per unit volume Counts (Arbitrary Units) Region R6 gate has been applied
  • 8. Statistical Analysis to Determine Decision Threshold using N = 253 samples Counts Scatter Plots of Bacterial Counts from Flow Cytometry N = 91 N = 162 N = 91 N = 162 Counts Mean Counts N = 91
  • 9. Statistical Analysis to Determine Decision Threshold using N = 253 samples Zooming in : Exception Analysis and Identifying the Gray Region This definitely could not have been negative by culture. We will look at other clinical investigations that were done on these samples N = 29 (18% of negatives) N = 68 (75% of positives) Counts Gray Region N = 17 (11% of negatives) N = 22 (24% of positives) Could these samples have all been similar in some respect? 0-3000 counts 3000-10000 counts > 10000 counts N = 116 (72% of negatives) N = 1 (1% of positives)
  • 10. Statistical Analysis of 253 Clinical Samples tested thus far Threshold defined using the training set. Threshold was set to ensure that NPV was 100% TP = True Positive at that level using culture as Gold Standard TN = True Negative at that level using culture as Gold Standard PPV - Positive Predictive Value NPV - Negative Predictive Value By Culture     By Culture By Flow CFU/mL Arb Units Negative < 10000 < 3,000 Positive > 100000 > 3,000 119 43 TN 99.2 NPV 67.7% PPV 1 Negative by Flow 90 Positive by Flow TP Overall
  • 11. Samples Stained with just TO without formaldehyde and stored at 4C overnight (N=22 samples) Y Axis: Counts measured on samples immediately after staining X Axis: Counts measured on samples stained and kept at 4 C for 24 hrs. No fixative was used Red Square Points: Indicative of False Positive samples as per culture results False Positive Zone: Samples that lie in this rectangle refer to those that show high counts deeming them positive, 24 hrs later, but were negative when counted immediately after staining False Negative Zone: Samples that lie in this rectangle refer to those that show low counts deeming them negative, 24 hrs later, but were positive when counted immediately after staining We find no samples in the False Positive or False Negative Zones. Thus the stained samples can be transported after fixing
  • 12. Transferring the assay to Diagnostic Lab : Instrument Set Up Protocol using ReaTCount Beads User will open SSC, FL1, FL2, FL3 histograms in a template and set the gains on these channels to get channel numbers within the specifications given below. On 5 different days the maximum variation seen for the same gain is no more than 2 channel numbers on any of the channels We ran experiments to determine , what is the variation that is tolerable (that does not impact counts by more than 10%) We have found that up-to 3 channel numbers variation about either side of the mean does not impact the counts seen in urine samples If the set up is within spec, the threshold is then set on FL1 at channel number 215
  • 13. Quantifying the Maximum Variability in Counts Seen with Assay Repeats (Assessing the robustness of the finalized assay protocol) 6 culture positive and 4 culture negative samples were filtered and stained in triplicate, to determine the assay variability seen with the finalized protocol. The assay variability is typically less than 15%. Thus the gray region for the threshold of 3000 is nearly +/- 450 counts
  • 14. ReaTCount Volume Control Beads FL3 – LDS stained cells are gated on R9 R9 gate is applied on FL1 to get counts using M1 Proof of concepts experiments – Dual Staining of Bacteria using LDS and Thiazole Orange NEGATIVE URINE SAMPLES POSITIVE URINE SAMPLES
  • 15.
  • 16. Manufactured by ReaMetrix India Pvt. Ltd. 50-B, II Phase, Peenya Industrial Area Peenya, Bangalore 560058, India Ph: +91-80-28378693/5, Fax: +91-80-41172451 E-mail: info@reametrix.com www.reametrix.com Further details: